Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2006

01.01.2006 | Laboratory Investigation

Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma

verfasst von: Claudia Auw-Haedrich, Rainer Sundmacher, Nikolaus Freudenberg, Helga Spelsberg, Nicolas Feltgen, Philip Maier, Thomas Reinhard

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

p63 is a homologue of the tumour suppressor gene p53, which is expressed in human basal squamous epithelium. Some investigators maintain that p63 plays a role in the development of squamous epithelium and, despite its homology to p53, it is considered to act as an oncogene. This study investigated the expression of p63 in conjunctival intraepithelial neoplasia of different grades, and conjunctival squamous cell carcinoma and its correlation to the proliferation marker MIB-1.

Material and methods

Seventeen conjunctival specimens excised with the suspicion of either conjunctival intraepithelial neoplasia (CIN) or squamous cell carcinoma were diagnosed histologically as follows: 2 squamous cell carcinomas of the conjunctiva, 2 CIN grade I, 3 CIN grade II, 7 CIN grade III, 2 CIN with beginning invasion and 1 normal conjunctiva with no dysplasia. Sixteen microscopically-normal postmortem conjunctival specimens and normal conjunctiva, CIN and carcinoma specimens were stained immunohistochemically with antibodies against p63 and MIB-1. At least 500 cells per specimen were counted and the percentage of positively-stained cells of each antibody was calculated.

Results

A mean of 80% (57–89%) of the dysplastic cells from the CIN specimens stained positively with antibodies against p63, especially in the lower two-thirds of the epithelium, statistically significantly more compared with the normal specimens (9–55%, mean 36%, p<0.001). Nevertheless, we did not find a correlation between the percentage of p63-positive cells and the differentiation grade of the malignant specimens. MIB-1 positivity was shown by 0–1% of the cells in the normal postmortem controls, by 3–30% (mean 12%) of the cells in the basal and occasionally in the middle layer of the CIN specimens, and 16–61% (mean 23%) in the carcinoma specimens.

Conclusion

In conjunctival intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, p63 is preferentially expressed in the immature dysplastic epithelial cells. Its staining does not correlate with MIB-1-expression, and therefore does not appear to be linked to cell proliferation.
Literatur
1.
Zurück zum Zitat Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996) Distinct pattern of chromosomal alterations in high- and low-grade head and neck squamous cell carcinoma. Cancer Res 56:5325–5329PubMed Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996) Distinct pattern of chromosomal alterations in high- and low-grade head and neck squamous cell carcinoma. Cancer Res 56:5325–5329PubMed
2.
Zurück zum Zitat Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221CrossRefPubMed Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221CrossRefPubMed
3.
Zurück zum Zitat Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 97:5462–5467CrossRefPubMed Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 97:5462–5467CrossRefPubMed
4.
Zurück zum Zitat Lee GA, Williams G, Hirst LW, Green AC (1994) Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101:360–364PubMed Lee GA, Williams G, Hirst LW, Green AC (1994) Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101:360–364PubMed
5.
6.
Zurück zum Zitat McDonnell JM, McDonnell PJ, Sun YY (1992) Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthamol Vis Sci 33:184–189 McDonnell JM, McDonnell PJ, Sun YY (1992) Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthamol Vis Sci 33:184–189
7.
Zurück zum Zitat Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 98:3156–3161CrossRefPubMed Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 98:3156–3161CrossRefPubMed
8.
Zurück zum Zitat Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD, Crum CP (2001) Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 80:24–29CrossRefPubMed Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD, Crum CP (2001) Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 80:24–29CrossRefPubMed
9.
Zurück zum Zitat Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 29:517–523CrossRefPubMed Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 29:517–523CrossRefPubMed
10.
Zurück zum Zitat Sakoonwatanyoo P, Tan DT, Smith DR (2004) Expression of p63 in pterygium and normal conjunctiva. Cornea 23:67–70CrossRefPubMed Sakoonwatanyoo P, Tan DT, Smith DR (2004) Expression of p63 in pterygium and normal conjunctiva. Cornea 23:67–70CrossRefPubMed
11.
Zurück zum Zitat Trink B et al (1998) A new human p53 homologue [see comment]. [Erratum appears in Nat Med 1998 4:982]. Comment in: Nat Med 1998 4:771. Nat Med 4:747–748CrossRefPubMed Trink B et al (1998) A new human p53 homologue [see comment]. [Erratum appears in Nat Med 1998 4:982]. Comment in: Nat Med 1998 4:771. Nat Med 4:747–748CrossRefPubMed
12.
Zurück zum Zitat Trosko JE, Krause D, Isoun M (1970) Sunlight-induced pyrimidine dimers in human cells in vitro. Nature 228:358–359CrossRefPubMed Trosko JE, Krause D, Isoun M (1970) Sunlight-induced pyrimidine dimers in human cells in vitro. Nature 228:358–359CrossRefPubMed
13.
Zurück zum Zitat Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305–316CrossRefPubMed Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305–316CrossRefPubMed
14.
Zurück zum Zitat Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718CrossRefPubMed Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718CrossRefPubMed
Metadaten
Titel
Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma
verfasst von
Claudia Auw-Haedrich
Rainer Sundmacher
Nikolaus Freudenberg
Helga Spelsberg
Nicolas Feltgen
Philip Maier
Thomas Reinhard
Publikationsdatum
01.01.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0025-4

Weitere Artikel der Ausgabe 1/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2006 Zur Ausgabe

Announcements

Announcements

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.